{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "Magazine", "lead_paragraph": "The hope to cure cancer rests on finding the right kind of drug. But what if we have to first find the right kind of cell?", "headline": {"seo": "The Riddle of Cancer Relapse", "main": "The Cancer Sleeper Cell", "print_headline": "The Cancer Sleeper Cell"}, "abstract": null, "print_page": "40", "word_count": "4585", "_id": "541c06fe7988100a1c660a60", "snippet": "The hope to cure cancer rests on finding the right kind of drug. But what if we have to first find the right kind of cell?", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2010/10/31/magazine/31Cancer-t.html", "multimedia": [], "subsection_name": null, "keywords": [{"rank": "1", "is_major": "N", "value": "Cancer", "name": "subject"}, {"rank": "2", "is_major": "N", "value": "Medicine and Health", "name": "subject"}], "byline": {"contributor": "", "person": [{"organization": "", "role": "reported", "firstname": "Siddhartha", "rank": 1, "lastname": "MUKHERJEE"}], "original": "By SIDDHARTHA MUKHERJEE"}, "document_type": "article", "pub_date": "2010-10-31T00:00:00Z", "section_name": "Magazine"}, {"type_of_material": "News", "blog": [], "news_desk": "Business", "lead_paragraph": "The new position, a shift in longstanding federal policy, will impact medicine and the biotechnology industry.", "headline": {"seo": "U.S. Says Genes Should Not Be Eligible for Patenting", "main": "U.S. Says Genes Should Not Be Eligible for Patents", "print_headline": "In a Policy Reversal, U.S. Says Genes Should Not Be Eligible for Patenting"}, "abstract": null, "print_page": "1", "word_count": "778", "_id": "541c37bb7988100a1c660ebc", "snippet": "The new position, a shift in longstanding federal policy, will impact medicine and the biotechnology industry.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2010/10/30/business/30drug.html", "multimedia": [], "subsection_name": null, "keywords": [{"value": "Genetics and Heredity", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Genetic Engineering", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Biotechnology", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Patent and Trademark Office", "is_major": "N", "rank": "4", "name": "organizations"}, {"value": "DNA (Deoxyribonucleic Acid)", "is_major": "N", "rank": "5", "name": "subject"}, {"value": "Justice Department", "is_major": "N", "rank": "6", "name": "organizations"}], "byline": {"contributor": "", "person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Andrew", "lastname": "POLLACK"}], "original": "By ANDREW POLLACK"}, "document_type": "article", "pub_date": "2010-10-30T00:00:00Z", "section_name": "Business Day"}, {"type_of_material": "News", "blog": [], "news_desk": "Business", "lead_paragraph": "Federal regulators seem to have heightened their scrutiny of diet pills that could pose risks.", "headline": {"seo": "Qnexa, a Diet Drug, Is Rejected by the F.D.A.", "main": "F.D.A. Rejects Qnexa, a Third Weight-Loss Drug", "print_headline": "With Safety Concerns Growing, F.D.A. Rejects Another Diet Pill"}, "abstract": null, "print_page": "1", "word_count": "1370", "_id": "541c2c6e7988100a1c660dbd", "snippet": "Federal regulators seem to have heightened their scrutiny of diet pills that could pose risks.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2010/10/29/health/policy/29drug.html", "multimedia": [{"width": 75, "url": "images/2010/10/29/business/29drug/29drug-thumbStandard.jpg", "height": 75, "subtype": "thumbnail", "legacy": {"thumbnailheight": "75", "thumbnail": "images/2010/10/29/business/29drug/29drug-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": "Money & Policy", "keywords": [{"rank": "1", "is_major": "N", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "2", "is_major": "N", "value": "Food and Drug Administration", "name": "organizations"}, {"rank": "3", "is_major": "N", "value": "Vivus Inc", "name": "organizations"}, {"rank": "4", "is_major": "N", "value": "Obesity", "name": "subject"}], "byline": {"contributor": "", "person": [{"organization": "", "role": "reported", "firstname": "Andrew", "rank": 1, "lastname": "POLLACK"}], "original": "By ANDREW POLLACK"}, "document_type": "article", "pub_date": "2010-10-29T00:00:00Z", "section_name": "Health"}], "meta": {"hits": 3, "offset": 0, "time": 44}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}